Global Obesity Drug Market Analysis and Forecasts to 2022

1
PharmaPoint Obesity Global Drug Forecast and
Market Analysis to 2022by GlobalData

• Explore all reports for Obesity Drugs market
• _at_
• http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals/diseases-treatment/obesity-dr
  ugs

2
PharmaPoint Obesity Global Drug Forecast and
Market Analysis to 2022

• The collection of Obesity Drugs market research
  reports has a new addition of PharmaPoint
  Obesity Global Drug Forecast and Market
  Analysis to 2022 on RnRMarketResearch.com. After
  a more than decade long dormancy, the Obesity
  market is undergoing a revival with the advent of
  several novel therapies that will lend
  considerable visibility to this indication space.
  This includes the use of combination therapies
  that simultaneously target multiple pathways and
  regulate appetite control, as well as novel
  molecular entities with new mechanisms of action.
  Due to this growing pipeline of late-stage drugs,
  this market is expected to experience substantial
  growth over the next decade. The main drivers of
  growth will be a large overweight and obese
  population that needs pharmacological
  intervention, the increasingly frequent
  prescription of pharmacological therapy as
  physicians make preemptive efforts to curtail
  disease progression with earlier treatment, as
  well as greater responsibility of third party
  payers for reimbursement and thus allow greater
  access of medications to patients. These factors
  will be particularly true in the emerging markets
  where uptake of branded drugs will increase due
  to rapid economic growth.
• Request a Sample Copy of this Report _at_
  http//www.rnrmarketresearch.com/contacts/request-
  sample?rname150338

3
PharmaPoint Obesity Global Drug Forecast and
Market Analysis to 2022

• Highlights
• Key Questions Answered
• The Obesity market is marked by the presence of
  several key unmet needs. What are these main
  unmet needs? Will the drugs under development
  fulfil these unmet needs? How do physicians and
  payers perceive these pipeline and currently
  marketed drugs?
• Only one older generation drug with modest
  efficacy had been available until the recent
  arrival of two new therapies that could
  potentially change the prescribing landscape.
  Will these drugs make a significant impact on the
  Obesity market? Which drugs are used off-label
  for the treatment of obesity?
• The diagnosed prevalence of Obesity in the world
  skyrocketed in the past 10 years and will
  continue increasing at a fast pace. How will
  epidemiological changes impact the growth of the
  future market? How does the burden of
  comorbidities associated with overweight and
  obesity impact the treatment algorithm?
• Complete Report is Available _at_ http//www.rnrmarke
  tresearch.com/pharmapoint-obesity-global-drug-fore
  cast-and-market-analysis-to-2022-market-report.htm
  l

4
PharmaPoint Obesity Global Drug Forecast and
Market Analysis to 2022

• Key Findings
• The main driver of growth of the Obesity market
  will be the growing population of overweight and
  obese individuals needing pharmacological
  intervention and the subsequent rise in the
  obesity-related comorbidities to put obesity at
  the forefront of the medical community as a
  veritable disease with life-threatening
  implications.
• The second largest driver will be the physicians
  efforts to delay disease progression through the
  use of combination therapies and novel branded
  drugs with greater efficacy and better safety
  profiles.
• To ensure patients gain access to novel,
  life-saving therapies, companies need to
  establish an agreement with third party payers to
  beholden them to a larger share of the
  responsibility for drug therapy reimbursement.
• To date, no drug has achieved blockbuster status.
  This unmet need presents a large opportunity for
  drug developers to capture an unoccupied market
  space.
• Request a Sample Copy of this Report _at_
  http//www.rnrmarketresearch.com/contacts/request-
  sample?rname150338

5
PharmaPoint Obesity Global Drug Forecast and
Market Analysis to 2022

• Scope
• Overview of Obesity, including epidemiology,
  etiology, pathophysiology, symptoms, diagnosis,
  and treatment guidelines.
• Annualized Obesity therapeutics market revenue,
  annual cost of therapy and treatment usage
  pattern data from 2012 and forecast for ten years
  to 2022.
• Key topics covered include strategic competitor
  assessment, market characterization, unmet needs,
  clinical trial mapping and implications for the
  Obesity therapeutics market.
• Pipeline analysis comprehensive data split
  across different phases, emerging novel trends
  under development, and detailed analysis of
  late-stage pipeline drugs.
• Analysis of the current and future market
  competition in the global Obesity therapeutics
  market. Insightful review of the key industry
  drivers, restraints and challenges. Each trend is
  independently researched to provide qualitative
  analysis of its implications.
• Complete Report is Available _at_ http//www.rnrmarke
  tresearch.com/pharmapoint-obesity-global-drug-fore
  cast-and-market-analysis-to-2022-market-report.htm
  l

6
PharmaPoint Obesity Global Drug Forecast and
Market Analysis to 2022

• Reasons to buy
• Develop and design in-licensing and out-licensing
  strategies through a review of pipeline products
  and technologies, and by identifying the
  companies with the most robust pipeline.
• Additionally a list of acquisition targets
  included in the pipeline product company list.
• Develop business strategies by understanding the
  trends shaping and driving the global Obesity
  therapeutics market.
• Drive revenues by understanding the key trends,
  innovative products and technologies, market
  segments, and companies likely to impact the
  global Obesity therapeutics market in the future.
• Formulate effective sales and marketing
  strategies by understanding the competitive
  landscape and by analysing the performance of
  various competitors.
• Identify emerging players with potentially strong
  product portfolios and create effective
  counter-strategies to gain a competitive
  advantage.
• Request a Sample Copy of this Report _at_
  http//www.rnrmarketresearch.com/contacts/request-
  sample?rname150338

7
PharmaPoint Obesity Global Drug Forecast and
Market Analysis to 2022

• Track drug sales in the global Obesity
  therapeutics market from 2012-2022.
• Organize sales and marketing efforts by
  identifying the market categories and segments
  that present maximum opportunities for
  consolidations, investments and strategic
  partnerships.
• Table of Contents
• 1 Table of Contents 81.1 List of Tables 111.2
  List of Figures 20
• 2 Introductions 242.1 Catalyst 252.2 Related
  Reports 262.3 Upcoming Related Reports 26
• 3 Disease Overview 273.1 Etiology and
  Pathophysiology 293.2 Symptoms 31
• Complete Report is Available _at_ http//www.rnrmarke
  tresearch.com/pharmapoint-obesity-global-drug-fore
  cast-and-market-analysis-to-2022-market-report.htm
  l

8
PharmaPoint Obesity Global Drug Forecast and
Market Analysis to 2022

• For more details contact Mr. Priyank Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

RnR Market Research RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR  Market Research library has
syndicated reports by leading market research 
publishers across the globe.